MedTech Breakthrough, an independent organisation that recognises the top companies and solutions in the global health and medical technology market, has recognised Sorrel Medical, a developer and manufacturer of wearable drug delivery devices, with the 'Best New Technology Solution in Drug Delivery' designation, it was reported yesterday.
The 'Best New Technology Solution' award, given in the drug delivery category, specifically honours Sorrel Medical's pre-filled and pre-loaded, wearable drug delivery platform, intended to offer patients a simple and efficient means of drug administration, particularly for large volume and high viscosity medications.
Andrei Yosef, PhD, CEO for Sorrel Medical, said, 'Sorrel is committed to providing simple and easy to use solutions that enhance the self-administration experience while encouraging adherence to treatment therapies. Creating a truly patient-centric experience, our devices are discreet, fully-disposable, and able to meet a variety of specific drug requirements from multiple pharmaceutical partners. We are honoured that our device platform and its accompanying technology has been designated as the Best New Technology Solution in the 2019 MedTech Breakthrough Awards Program.'
TELA Bio launches LIQUIFIX for US hernia surgery
Cognizant and NVIDIA partner to revolutionize drug discovery with generative AI
Neupulse raises funds for Tourettes Syndrome wearable tech
Bonesupport gains FDA clearance for CERAMENT G in open fractures
Epitomee submits Weight Loss Capsule for FDA approval in US
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon